MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine

被引:145
作者
Sauane, M
Gopalkrishnan, RV
Sarkar, D
Su, ZZ
Lebedeva, IV
Dent, P
Pestka, S
Fisher, PB
机构
[1] Columbia Univ Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Pathol, New York, NY 10032 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Oncol, Richmond, VA 23298 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet, Piscataway, NJ 08854 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol, Piscataway, NJ 08854 USA
[5] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Immunol, Piscataway, NJ 08854 USA
[6] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Neurosurg, New York, NY 10032 USA
[7] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Dept Urol, New York, NY 10032 USA
关键词
gene therapy; signal transduction; IL-10-related cytokine; differentiation; interleukin receptor;
D O I
10.1016/S1359-6101(02)00074-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The melanoma differentiation-associated gene-7 (mda-7) was cloned by subtraction hybridization as a molecule whose expression is elevated in terminally differentiated human melanoma cells. Current information based on structural and sequence homology, has led to the recognition of MDA-7 as an IL-10 family cytokine member and its renaming as IL-24. Northern blot analysis revealed mda-7/IL-24 expression in human tissues associated with the immune system such as spleen, thymus, peripheral blood leukocytes and normal melanocytes. The MDA-7/IL-24 mouse counterpart, FISP, appears to be a Th2-specific protein and the rat counterpart, C49A/MOB-5, is associated with wound healing and is also induced as a consequence of ras-transformation. A notable property of MDA-7/IL-24 is its ability to induce apoptosis in a large spectrum of human cancer derived cell lines, in mouse xenografts and upon intratumoral injection in human minors (phase I clinical trials). Various aspects of this intriguing molecule including its cytokine and anti-tumoral effects are described and discussed. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:35 / 51
页数:17
相关论文
共 97 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]   Novel developments with the PRINTS protein fingerprint database [J].
Attwood, TK ;
Beck, ME ;
Bleasby, AJ ;
Degtyarenko, K ;
Michie, AD ;
ParrySmith, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (01) :212-216
[3]   PROSITE - A DICTIONARY OF SITES AND PATTERNS IN PROTEINS [J].
BAIROCH, A .
NUCLEIC ACIDS RESEARCH, 1991, 19 :2241-2245
[4]  
Baldi A, 1996, CLIN CANCER RES, V2, P1239
[5]   Interleukin 20: Discovery, receptor identification, and role in epidermal function [J].
Blumberg, H ;
Conklin, D ;
Xu, WF ;
Grossmann, A ;
Brender, T ;
Carollo, S ;
Eagan, M ;
Foster, D ;
Haldeman, BA ;
Hammond, A ;
Haugen, H ;
Jelinek, L ;
Kelly, JD ;
Madden, K ;
Maurer, MF ;
Parrish-Novak, J ;
Prunkard, D ;
Sexson, S ;
Sprecher, C ;
Waggie, K ;
West, J ;
Whitmore, TE ;
Yao, L ;
Kuechle, MK ;
Dale, BA ;
Chandrasekher, YA .
CELL, 2001, 104 (01) :9-19
[6]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[7]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[8]   The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24 [J].
Caudell, EG ;
Mumm, JB ;
Poindexter, N ;
Ekmekcioglu, S ;
Mhashilkar, AM ;
Yang, XHH ;
Retter, MW ;
Hill, P ;
Chada, S ;
Grimm, EA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6041-6046
[9]  
Chadbourne DE, 2001, POPTRONICS, V2, P3
[10]  
Chai SK, 1997, J IMMUNOL, V159, P4720